MORGAN STANLEY PLC/CALL/MEDTRONIC/120/0.1/20.06.25 Share Price

Warrant

DE000ME3YH77

Real-time Bid/Ask 18:05:31 12/06/2024 BST
0.061 EUR / 0.063 EUR +6.90% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/120/0.1/20.06.25
Current month+18.37%
1 month-9.38%
Date Price Change
12/06/24 0.061 +5.17%
11/06/24 0.058 0.00%
10/06/24 0.058 +5.45%
07/06/24 0.055 +5.77%
06/06/24 0.052 +6.12%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 05:59 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN ME3YH7
ISINDE000ME3YH77
Date issued 21/11/2023
Strike 120 $
Maturity 20/06/2025 (373 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.151
Lowest since issue 0.044
Spread 0.002
Spread %3.17%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.95 USD
Average target price
94.07 USD
Spread / Average Target
+14.79%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW